Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Deep and brainstem cavernomas: a consecutive 8-year series.

Tiit Mathiesen1, Göran Edner, Lars Kihlström

  • 1Section of Neurosurgery, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden. tiit.mathiesen@ks.se

Journal of Neurosurgery
|July 12, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CGRP-targeted migraine treatment and early pathophysiology in experimental subarachnoid hemorrhage.

The journal of headache and pain·2026
Same author

Ethical aspects of waiting lists in neurosurgery.

Acta neurochirurgica·2026
Same author

The Ki-67 proliferation index and recurrence risk of intracranial meningioma: a multicenter, retrospective cohort study of 5,050 patients.

Acta neurochirurgica·2026
Same author

A Supportive Group Intervention for Caregivers to Patients Diagnosed With Glioblastoma: Protocol for the SUGRI Study.

JMIR research protocols·2026
Same author

Ethical issues in neurosurgery - A scoping review from the EANS Ethico-legal committee.

Brain & spine·2026
Same author

Fractionated radiotherapy adjuvant to surgery of WHO-2 meningioma with and without gross total resection: a multicenter, retrospective cohort study of 1,452 patients.

Journal of neuro-oncology·2026
Same journal

Extent of resection as an independent predictor of survival for patients with glioblastoma as defined by the new WHO 2021 classification.

Journal of neurosurgery·2026
Same journal

Surgical treatment of schwannomas around the tarsal tunnel: a case series of 40 patients and systematic review of the literature.

Journal of neurosurgery·2026
Same journal

Direct targeting for focused ultrasound thalamotomy in the treatment of movement disorders.

Journal of neurosurgery·2026
Same journal

Development and internal validation of the Meningioma Functional Outcome Risk and Counseling Estimator 6 score, a point-based prognostic tool for predicting 6-week functional independence after intracranial meningioma resection.

Journal of neurosurgery·2026
Same journal

Connectional anatomy of the cerebellum: dentate nucleus and cerebellar peduncles from a surgical perspective.

Journal of neurosurgery·2026
Same journal

Press releases in neurosurgery: is scientific accuracy compromised in public reporting of neurosurgery research?

Journal of neurosurgery·2026
See all related articles

Microsurgery offers better long-term outcomes for symptomatic basal ganglia and brainstem cavernomas compared to conservative management. Early surgical intervention, within 10-30 days post-hemorrhage, may improve results and reduce patient morbidity.

Area of Science:

  • Neurosurgery
  • Neurology
  • Epidemiology

Background:

  • Cavernomas of the basal ganglia and brainstem are challenging neurosurgical lesions.
  • Long-term data on the management of these deep-seated cavernomas are limited.

Purpose of the Study:

  • To provide epidemiological and clinical data on the management of basal ganglia and brainstem cavernomas.
  • To evaluate the long-term outcomes of different treatment modalities.

Main Methods:

  • Retrospective review of 68 patients with deep cavernomas treated between 1992 and 2000.
  • Analysis of clinical data, neuroimaging, and surgical outcomes.
  • Comparison of microsurgery, gamma knife surgery, and conservative management.

Main Results:

Related Experiment Videos

  • Microsurgery achieved radical excision in 25/29 patients, with a 69% risk of transient neurological deterioration.
  • Early surgery (within 1 month post-hemorrhage) yielded better results than delayed surgery.
  • Conservative management and shunt surgery had worse long-term outcomes than microsurgery for symptomatic cavernomas.
  • Incidental cavernomas had a low yearly hemorrhage incidence (2%), while symptomatic ones had a higher rate (7%).

Conclusions:

  • Microsurgery is superior to conservative treatment for symptomatic cavernomas of the basal ganglia and brainstem.
  • Total tumor removal should be prioritized when safely achievable.
  • Optimal timing for surgery may be within 10 to 30 days following a hemorrhage.